Delivery Order SPE2DR25D2003-SPE2DR26FR07C
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,163.33 to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector auto-injector packs (2-count) on November 11, 2025, with completion scheduled for November 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Epinephrine 0.3 mg auto-injector packs valued at $2,954.20. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of June 17, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a single delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs with a ceiling value of $4,651.20. This competitive award, executed on a firm fixed-price basis with no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract specifies a performance location in Conshohocken,...
- The Defense Logistics Agency awarded a $5,569.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.15 mg auto-injectors (2-pack units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 10, 2025, for the supply of Epinephrine 0.3 mg auto-injector 2-packs at a fixed price of $1,430.27. This is a non-set-aside contract representing a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement valued through December 2026. The contract will be fulfilled from the...
- The Defense Logistics Agency awarded a $2,358.98 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of epinephrine 0.3 mg auto-injector two-packs. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 7, 2026, and performance will be executed from the awardee's facility in Conshohocken, Pennsylvania. The delivery order represents a tactical procurement under AmerisourceBergen's broader pharmaceutical supply relationship...
- The Defense Logistics Agency has awarded a delivery order valued at $1,797.24 to AmerisourceBergen Drug Corp for the supply of Epinephrine 0.3 mg auto-injector 2-packs. The contract is a firm fixed price delivery order with no set-aside designation, reflecting a competitively awarded transaction. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The ultimate completion date is November 18, 2025, with the award...
- The Defense Logistics Agency awarded a $1,413.12 delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Epinephrine 0.15 mg auto-injectors (2-pack). This firm fixed-price contract, with an ultimate completion date of August 6, 2025, represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The award was competitively made with no set-aside designation, and performance will occur at the contractor's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Epinephrine 0.3 mg auto-injector two-packs, with a ceiling value of $1,477.10 and an ultimate completion date of August 25, 2025. This competitively awarded, non-set-aside contract reflects firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger federal contract vehicle with the Defense Logistics Agency. The place of performance is...
- The Defense Logistics Agency awarded a $3,114.17 delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector, 2-pack units. This contract was competitively awarded without set-aside provisions and is expected to be completed by November 21, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, utilizing firm fixed-price delivery order terms. This award represents a child contract executed under the vendor's broader...
- SPE2DR25D2003Indefinite Delivery Contract
- SPE2DR25D2003-SPE2DR26FR07CDelivery Order
The Defense Logistics Agency awarded a $1,172.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp for epinephrine 0.3 mg auto-injector 2-packs. The award, issued on January 6, 2026, with an ultimate completion date of January 7, 2026, represents a child delivery order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. This contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems, delivering this emergency medication to support military medical supply chain requirements. The delivery order falls under the DLA Troop Support Medical's comprehensive pharmaceutical prime vendor contract vehicle, which is valued at up to $999,999,999.00 and extends through December 2026. This contract structure enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical devices, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The epinephrine auto-injectors being delivered under this order represent critical emergency medical supplies essential for treating anaphylaxis in military treatment facilities and veteran healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 1/5/26 |